Free Trial

Pfizer, Moderna Jabs Retain High Trust; AZ, Sputnik Lower

GLOBAL POLITICAL RISK

Latest global polling from YouGov on trust in COVID-19 vaccines shows widespread trust in the two most prominent mRNA vaccines from Pfizer/BioNTech and Moderna, while Johnson & Johnson's single-dose vaccine, Russia's Sputnik-V, and the UK's Oxford/AstraZeneca vaccines all scored lower in the trust ratings. The lowest scoring vaccines of all were the Sinopharm and Sinovac vaccines developed in China, and Covaxin, developed in India.

Chart 1. How safe, or unsafe, do you think the [X] vaccine is? Net safety shown.

Source: YouGov. 6-25 June 2021. N.b. Each dot represents one country's net safety rating.

  • Trust in the Pfizer and Moderna vaccines is almost uniformly high across the board, with Bulgaria and France two outliers on the low side. However, both of these countries have high levels of vaccine hesitancy in general, with all other vaccines also receiving low trust scores from these nations.
  • The UK is by some distance the most trusting of the AstraZeneca vaccine, perhaps not surprising given that it was the backbone of the country's rapid initial rollout. Trust in the US (where it is not approved) and many EU member states (where it has been either pulled from rollout or pulled from younger people) is also low.
  • In a number of western states, vaccine uptake is beginning to plateau as those vulnerable to the coronavirus are increasingly double-vaccinated while younger people aged 18-30 are not coming forward in significant numbers to receive the vaccine.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.